India’s pre-wedding boom fuels demand for weight-loss injections despite regulatory concerns
“We understand the curiosity, but this cannot be a quick fix,” said Dr. Swati Pradhan, highlighting concerns over misuse of
Read More
Factual Version of a Story
Wegovy
Novo Nordisk and Eli Lilly Reject Claims of Partnership with Mangoceuticals on Obesity Drugs
Novo Nordisk and Eli Lilly clarify that they have no collaboration or special arrangement with telehealth firm Mangoceuticals, following misleading
Read More
Eli Lilly’s Mounjaro Becomes India’s Top-Selling Drug, Signaling a New Era in Healthcare Innovation
Hyderabad – Eli Lilly’s groundbreaking weight-loss and diabetes treatment, Mounjaro, takes the top spot in India’s pharmaceutical market, marking a
Read More
U.S. Strikes Breakthrough Deal to Boost Access to Weight-Loss Drugs
A landmark public-private partnership aims to make life-changing obesity and diabetes treatments more affordable and accessible for millions across America.
Read More
Novo Nordisk’s New Power Lineup: A Fresh Era of Leadership and Strategy
Novo Nordisk ushers in a new leadership team blending deep industry experience, scientific excellence, and strategic vision. In a move
Read More
Bill Gates and PAHO Explore Affordable Access to Weight-Loss Drugs for Developing Nations
London – In a move that could reshape global health access, philanthropist Bill Gates and the Pan American Health Organization
Read More